Resumen
We describe a patient who developed dilated cardiomyopathy and clinical congestive heart failure after 2 months of therapy with amphotericin B (AmB) for disseminated coccidioidomycosis. His echocardiographic abnormalities and heart failure resolved after posaconazole was substituted for AmB. It is important to recognize the rare and potentially reversible toxicity of AmB.
| Idioma original | English (US) |
|---|---|
| Páginas (desde-hasta) | 115-117 |
| Número de páginas | 3 |
| Publicación | Journal of Antimicrobial Chemotherapy |
| Volumen | 53 |
| N.º | 1 |
| DOI | |
| Estado | Published - ene 2004 |
ASJC Scopus subject areas
- Pharmacology
- Microbiology (medical)
- Infectious Diseases
- Pharmacology (medical)
Huella
Profundice en los temas de investigación de 'Reversible dilated cardiomyopathy related to amphotericin B therapy'. En conjunto forman una huella única.Citar esto
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS